Nuveen LLC Acquires Shares of 312,170 Aveanna Healthcare Holdings Inc. $AVAH

Key Points

• Nuveen LLC has acquired a stake in Aveanna Healthcare Holdings Inc. by purchasing 312,170 shares valued at approximately $1.69 million, representing 0.16% ownership of the company.
• Multiple analysts have upgraded their ratings for Aveanna Healthcare, with a consensus average target price now at $7.50 following a series of positive evaluations from firms such as Raymond James and Barclays.
• A significant insider transaction was reported, with major shareholder J.H. Whitney Equity Partners V selling 750,000 shares, marking a 2.53% decrease in their position.

Nuveen LLC bought a new stake in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 312,170 shares of the company's stock, valued at approximately $1,692,000. Nuveen LLC owned approximately 0.16% of Aveanna Healthcare at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Millennium Management LLC boosted its position in shares of Aveanna Healthcare by 105.0% during the 4th quarter. Millennium Management LLC now owns 400,374 shares of the company's stock valued at $1,830,000 after purchasing an additional 205,023 shares in the last quarter. Deutsche Bank AG boosted its position in shares of Aveanna Healthcare by 32.1% during the 4th quarter. Deutsche Bank AG now owns 34,564 shares of the company's stock valued at $158,000 after purchasing an additional 8,396 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in Aveanna Healthcare in the fourth quarter worth approximately $223,000. Teacher Retirement System of Texas boosted its holdings in Aveanna Healthcare by 50.9% in the first quarter. Teacher Retirement System of Texas now owns 49,881 shares of the company's stock worth $270,000 after acquiring an additional 16,835 shares in the last quarter. Finally, Rhumbline Advisers boosted its holdings in Aveanna Healthcare by 4.0% in the first quarter. Rhumbline Advisers now owns 75,581 shares of the company's stock worth $410,000 after acquiring an additional 2,918 shares in the last quarter. Institutional investors own 87.96% of the company's stock.

Insider Activity at Aveanna Healthcare

In related news, major shareholder Robert M. Williams, Jr. sold 750,000 shares of the stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $5.20, for a total transaction of $3,900,000.00. Following the completion of the sale, the insider directly owned 28,890,756 shares of the company's stock, valued at approximately $150,231,931.20. This trade represents a 2.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, major shareholder J.H. Whitney Equity Partners V sold 750,000 shares of the stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $5.20, for a total value of $3,900,000.00. Following the sale, the insider directly owned 28,890,756 shares of the company's stock, valued at $150,231,931.20. The trade was a 2.53% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 2,295,145 shares of company stock valued at $11,941,141 in the last ninety days. Insiders own 7.80% of the company's stock.

Analyst Upgrades and Downgrades

AVAH has been the topic of several recent research reports. Wall Street Zen upgraded Aveanna Healthcare from a "buy" rating to a "strong-buy" rating in a report on Saturday, August 9th. Raymond James Financial upgraded Aveanna Healthcare from a "market perform" rating to an "outperform" rating and set a $9.00 price target on the stock in a report on Monday, August 11th. Jefferies Financial Group upgraded Aveanna Healthcare from a "hold" rating to a "buy" rating and cut their price target for the stock from $6.25 to $6.00 in a report on Monday, July 21st. Truist Financial lowered their price objective on Aveanna Healthcare from $6.00 to $5.00 and set a "hold" rating for the company in a research note on Wednesday, July 16th. Finally, UBS Group raised Aveanna Healthcare from a "sell" rating to a "neutral" rating and increased their price objective for the stock from $6.75 to $8.00 in a research note on Tuesday, August 19th. Three investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $7.50.

Aveanna Healthcare Trading Down 3.1%

Shares of AVAH traded down $0.26 on Thursday, reaching $8.08. 1,358,492 shares of the company's stock traded hands, compared to its average volume of 2,158,128. The stock has a market cap of $1.69 billion, a PE ratio of 101.00 and a beta of 2.04. The stock's 50 day simple moving average is $5.53 and its two-hundred day simple moving average is $5.15. Aveanna Healthcare Holdings Inc. has a 52-week low of $3.67 and a 52-week high of $8.41.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.